These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 9488046

  • 1. Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.
    Greco A, Fusetti L, Miranda C, Villa R, Zanotti S, Pagliardini S, Pierotti MA.
    Oncogene; 1998 Feb 12; 16(6):809-16. PubMed ID: 9488046
    [Abstract] [Full Text] [Related]

  • 2. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
    Roccato E, Pagliardini S, Cleris L, Canevari S, Formelli F, Pierotti MA, Greco A.
    Oncogene; 2003 Feb 13; 22(6):807-18. PubMed ID: 12584559
    [Abstract] [Full Text] [Related]

  • 3. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M, Pierotti MA.
    Mol Cell Biol; 1995 Nov 13; 15(11):6118-27. PubMed ID: 7565764
    [Abstract] [Full Text] [Related]

  • 4. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A, Thraves PJ, Dritschilo A, Notario V.
    Oncogene; 1996 Oct 17; 13(8):1755-63. PubMed ID: 8895522
    [Abstract] [Full Text] [Related]

  • 5. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
    Greco A, Miranda C, Pagliardini S, Fusetti L, Bongarzone I, Pierotti MA.
    Genes Chromosomes Cancer; 1997 Jun 17; 19(2):112-23. PubMed ID: 9172002
    [Abstract] [Full Text] [Related]

  • 6. Xenopus laevis TRK-fused gene (TFG) is an SH3 domain binding protein highly expressed in the cement gland.
    Ohan N, Sabourin D, Booth RA, Liu XJ.
    Mol Reprod Dev; 2000 Jul 17; 56(3):336-44. PubMed ID: 10861999
    [Abstract] [Full Text] [Related]

  • 7. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
    Butti MG, Bongarzone I, Ferraresi G, Mondellini P, Borrello MG, Pierotti MA.
    Genomics; 1995 Jul 01; 28(1):15-24. PubMed ID: 7590742
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
    Greco A, Mariani C, Miranda C, Pagliardini S, Pierotti MA.
    Genomics; 1993 Nov 01; 18(2):397-400. PubMed ID: 8288244
    [Abstract] [Full Text] [Related]

  • 10. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A, Pierotti MA, Bongarzone I, Pagliardini S, Lanzi C, Della Porta G.
    Oncogene; 1992 Feb 01; 7(2):237-42. PubMed ID: 1532241
    [Abstract] [Full Text] [Related]

  • 11. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
    Mitra G.
    Oncogene; 1991 Dec 01; 6(12):2237-41. PubMed ID: 1837350
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structural and functional domains critical for constitutive activation of the HGF-receptor (Met).
    Zhen Z, Giordano S, Longati P, Medico E, Campiglio M, Comoglio PM.
    Oncogene; 1994 Jun 01; 9(6):1691-7. PubMed ID: 8183564
    [Abstract] [Full Text] [Related]

  • 14. Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
    Greco A, Orlandi R, Mariani C, Miranda C, Borrello MG, Cattaneo A, Pagliardini S, Pierotti MA.
    Cell Growth Differ; 1993 Jul 01; 4(7):539-46. PubMed ID: 8398895
    [Abstract] [Full Text] [Related]

  • 15. [Neurotrophins. I: Molecular features].
    Zazpe A, Del Río J.
    Rev Med Univ Navarra; 1997 Jul 01; 41(3):173-9. PubMed ID: 10420923
    [Abstract] [Full Text] [Related]

  • 16. A novel modular mosaic of cell adhesion motifs in the extracellular domains of the neurogenic trk and trkB tyrosine kinase receptors.
    Schneider R, Schweiger M.
    Oncogene; 1991 Oct 01; 6(10):1807-11. PubMed ID: 1656363
    [Abstract] [Full Text] [Related]

  • 17. Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc.
    Roccato E, Miranda C, Ranzi V, Gishizki M, Pierotti MA, Greco A.
    Br J Cancer; 2002 Sep 09; 87(6):645-53. PubMed ID: 12237775
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH, Knezevich SR, Lucas T, Jansen B, Kay RJ, Sorensen PH.
    Oncogene; 2000 Feb 17; 19(7):906-15. PubMed ID: 10702799
    [Abstract] [Full Text] [Related]

  • 20. The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.
    Ranzi V, Meakin SO, Miranda C, Mondellini P, Pierotti MA, Greco A.
    Endocrinology; 2003 Mar 17; 144(3):922-8. PubMed ID: 12586769
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.